Offer StarStarter Rx to your patients to improve their mental health outcomes and engagement
StarStarter Rx has begun a limited
release with select healthcare organizations
- StarStarter Rx is a digital therapeutic that applies the cognitive training technique Attention Bias Modification (ABM) through an engaging mobile game
- Indicated to reduce social anxiety symptoms for patients 13-65 with Social Anxiety Disorder (SAD)*
- >90% effective at reducing social anxiety symptoms by an average of 33%, after 30 day treatment using our game just 4 times a week
- Currently pursuing FDA submission as a treatment for SAD
Social Anxiety Disorder (SAD)
- SAD is the most prevalent of anxiety disorders, more than twice that of Generalized Anxiety Disorder, with cases rising as many are now re-entering social situations after prolonged isolation.
- Pre-pandemic, 7% of the US population was affected by SAD annually
- The most validated and frequently used clinical assessment of social anxiety, the Liebowitz Social Anxiety Scale or LSAS, is the primary endpoint of our research.
Source: NIMH
Integrated Deployment is Supported by Our Arcade Connect Platform
- Manages distribution of our products to various patient populations
- HIPAA-compliant, secure system with patient consents and clinical workflow integration
- Supports health care provider reimbursement for remote therapeutic monitoring of patient’s course of treatment
Our Approach Has Shown a Significant Impact on Patient Engagement and Outcomes Through Real World Clinical Pilots
30-DAY ADHERENCE:
1
%
1
%
1
%
TARGETED DEPLOYMENTS ACROSS:
- Primary Care
- Behavioral Health
- Tele-Health / Virtual Care
- Collaborative Care
- Chronic Care
- Women’s Health
Clinical partners
Inquire Below
Fill in your information on the form below to offer StarStarter Rx to your patients.
Low-stigma treatment for social anxiety disorder
Clinically validated and science-based micro intervention
Detailed reporting on stress and anxiety over time
Improve patient outcomes and engagement
